GICARE PHARMA
Founded in 2011, gIcare Pharma Inc is a biopharmaceutical, start-up company, which develops novel gastrointestinal drugs. Led by a dynamic management highly experienced in gastroenteolorogy, the Company's intent is to develop innovative medicines which align with currently unmet medical needs. While innovation should be, above all, primarily beneficial to patients, gIcare Pharma believes that any novel drug should also provide clinical benefits to physicians as well as pharmaco-economic advantages to third-party payers. gIcare's flagship drug candidate, GIC-1001, combines these multi-level benefits and is the best example of what innovation means to us.
GICARE PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.gicarepharma.com
Total Employee:
1+
Status:
Active
Contact:
514-825-9035
Email Addresses:
[email protected]
Total Funding:
7 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Founder
Investors List
Genesys Capital
Genesys Capital investment in Series A - gIcare Pharma
Forbion Capital Partners
Forbion Capital Partners investment in Series A - gIcare Pharma
